Publication | Open Access

Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)

MedicinePathologyInduction CetuximabHead And Neck CancerStage Iii/iv HeadCancer TreatmentNeck OncologyOncologyRadiation OncologyCancer ResearchNeck Squamous Cancer